T1	Participants 60 132	adults with soft tissue sarcomas of the head and neck, breast, and trunk
T2	Participants 135 158	Since 1977, 31 patients
T3	Participants 253 382	after aggressive local treatment of high-grade sarcomas of the head, neck, breast, and trunk (excluding retroperitoneal sarcomas)
T4	Participants 384 507	All patients had complete resection of gross tumor and underwent postoperative radiotherapy (6000-6300 rads over 7-8 weeks)
T5	Participants 1292 1523	An additional 26 patients were treated in an identical fashion, but were not part of the randomized trial because of contraindications to chemotherapy, refusal to enter the randomized trial, or because they were treated before 1977
T6	Participants 1596 1623	entire group of 57 patients
